Medicare beneficiaries who are already receiving coverage from their Part D plan for a GLP-1 for a Medicare-covered use, such as type 2 diabetes, cardiovascular disease risk reduction, or sleep apnea, will continue to access the drug through their Part D plan and not through the Medicare GLP-1 Bridge, which will only provide coverage of GLP-1s when used for obesity
How is the FDA Responding to the Compounded GLP-1 Surge
Additionally, Semaglutide reduces oxidative stress by decreasing the production of reactive oxygen species (ROS) and increasing the activity of antioxidant enzymes
I'm Catherine Eager, with Vitamin Group on behalf of our client, DentaQuest
If you continue to take the same dosage of your existing blood pressure medication (such as ACE inhibitors, beta-blockers, or diuretics), your blood pressure could potentially drop too low